Xitch-LZ Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Xitch-LZ Cream is applied topically to the affected area once daily, typically for a duration of 2 to 4 weeks depending on the severity and location of the infection. It is well tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, itching, or erythema at the application site. The cream should be used as directed by a healthcare professional, avoiding contact with eyes and mucous membranes. It is contraindicated in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. Xitch-LZ Cream offers an effective and convenient treatment option for dermatophytic infections, promoting resolution of symptoms and preventing recurrence when used in accordance with prescribed guidelines.